Caixia Li

561 total citations
24 papers, 332 citations indexed

About

Caixia Li is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Caixia Li has authored 24 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Caixia Li's work include CAR-T cell therapy research (7 papers), Virus-based gene therapy research (2 papers) and Immune Cell Function and Interaction (2 papers). Caixia Li is often cited by papers focused on CAR-T cell therapy research (7 papers), Virus-based gene therapy research (2 papers) and Immune Cell Function and Interaction (2 papers). Caixia Li collaborates with scholars based in China, Pakistan and United States. Caixia Li's co-authors include Wen Zhou, Yutong Hao, Chunhai Chen, Zhengping Yu, Depei Wu, Liqing Kang, Lei Yu, Zhengming Jin, Aihua Ye and Nana Ping and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Caixia Li

22 papers receiving 330 citations

Peers

Caixia Li
Catherine M. Albert United States
Jared S. Rosenblum United States
Elias Orouji Germany
Winnie Yao United States
Simona Santangelo Italy
Giacomo Sferruzza Italy
Mitchell Sun United States
Evan Weber Canada
Qiuyu Zhang China
Catherine M. Albert United States
Caixia Li
Citations per year, relative to Caixia Li Caixia Li (= 1×) peers Catherine M. Albert

Countries citing papers authored by Caixia Li

Since Specialization
Citations

This map shows the geographic impact of Caixia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caixia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caixia Li more than expected).

Fields of papers citing papers by Caixia Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caixia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caixia Li. The network helps show where Caixia Li may publish in the future.

Co-authorship network of co-authors of Caixia Li

This figure shows the co-authorship network connecting the top 25 collaborators of Caixia Li. A scholar is included among the top collaborators of Caixia Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caixia Li. Caixia Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ouyang, Huizi, Xiwei Wu, Caixia Li, et al.. (2024). Investigation of the drug–drug interaction and incompatibility mechanism between Aconitum carmichaelii Debx and Pinellia ternata (Thunb.) Breit. Journal of Ethnopharmacology. 330. 118212–118212. 1 indexed citations
3.
Li, Caixia, et al.. (2023). Comprehensive Analysis Reveals Distinct Immunological and Prognostic Characteristics of CD276/B7-H3 in Pan-Cancer. International Journal of General Medicine. Volume 16. 367–391. 7 indexed citations
4.
Xu, Xuerong, et al.. (2022). Main Nutritional and Functional Ingredients and Antioxidant Evaluation of Xanthoceras sorbifolia Bunge Bud Tea and Leaf Tea. SHILAP Revista de lepidopterología. 1 indexed citations
5.
Sang, Wei, Xiangmin Wang, Tianci Li, et al.. (2022). Anti-PD-1 Therapy Enhances the Efficacy of CD30-Directed Chimeric Antigen Receptor T Cell Therapy in Patients With Relapsed/Refractory CD30+ Lymphoma. Frontiers in Immunology. 13. 858021–858021. 37 indexed citations
6.
7.
Zhang, Ying, Jiaqi Li, Xiaoyan Lou, et al.. (2021). A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma. Frontiers in Oncology. 11. 664421–664421. 35 indexed citations
8.
9.
10.
11.
Cheng, Zhongping, et al.. (2020). Laparoscopic regional radical hysterectomy showed promising clinical outcomes in early-stage cervical cancer. Gynecology and Minimally Invasive Therapy. 9(4). 220–220. 4 indexed citations
12.
Kang, Liqing, Xiaowen Tang, Nan Xu, et al.. (2019). shRNA-Interleukin-6 Modified CD19-Specific Chimeric Antigen Receptor T Cell Significantly Improves the Safety in Acute Lymphoblastic Leukemia. Blood. 134(Supplement_1). 2621–2621. 2 indexed citations
13.
Li, Caixia, Changfeng Zhang, Xiaochen Chen, et al.. (2019). Relative Depletion of Soluble Interleukin 6 Receptors Abolished the Development of Cytokine Release Syndrome after CART19/22 and Lenalidomide Treatment for Lymphoma. Blood. 134(Supplement_1). 5313–5313. 3 indexed citations
14.
Shao, Guoliang, Ruibao Liu, Wenbin Ding, et al.. (2018). Efficacy and safety of raltitrexed-based transarterial chemoembolization for colorectal cancer liver metastases. Anti-Cancer Drugs. 29(10). 1021–1025. 7 indexed citations
15.
16.
Li, Caixia, et al.. (2018). Correlation of LOX‑5 and COX‑2 expression with inflammatory pathology and clinical features of adenomyosis. Molecular Medicine Reports. 19(1). 727–733. 18 indexed citations
17.
Li, Caixia, et al.. (2016). [Peripheral blood endothelial progenitor cells enhance the expressions of SDF-1 and MCP-1 of bone marrow stromal cells and promote their homing ability].. PubMed. 32(1). 20–4. 1 indexed citations
18.
Wang, Huiling, et al.. (2015). TGF-β1 Reduces miR-29a Expression to Promote Tumorigenicity and Metastasis of Cholangiocarcinoma by Targeting HDAC4. PLoS ONE. 10(10). e0136703–e0136703. 22 indexed citations
19.
Li, Caixia, et al.. (2008). Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1α activation. Biochemical and Biophysical Research Communications. 371(2). 283–288. 75 indexed citations
20.
Xia, Yunfeng, Youji Li, Yong Du, et al.. (2006). Association of MEGSIN 2093C–2180T haplotype at the 3′ untranslated region with disease severity and progression of IgA nephropathy. Nephrology Dialysis Transplantation. 21(6). 1570–1574. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine M. Albert Breakdown of academic impact, for papers by Jared S. Rosenblum Breakdown of academic impact, for papers by Elias Orouji Breakdown of academic impact, for papers by Winnie Yao Breakdown of academic impact, for papers by Simona Santangelo Breakdown of academic impact, for papers by Giacomo Sferruzza Breakdown of academic impact, for papers by Mitchell Sun Breakdown of academic impact, for papers by Evan Weber Breakdown of academic impact, for papers by Qiuyu Zhang
Rankless by CCL
2026